Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

Part of paid clinical trials in Dallas, Texas.

Sponsor
yair lotan
Study ID
NCT02064673
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
30 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Curcumin — DRUG
    Curcumin or placebo 500mg by mouth twice a day for 6 months
  • placebo — DRUG
    placebo orally twice a day

Study Details

This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.

Key Dates

Start date
May 31, 2014
Status verified
Mar 2026
Primary completion
Jun 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
650 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Active Comparator: Curcumin
    Curcumin 500 mg orally twice a day
  • Placebo Comparator: sugar pill
    placebo orally twice a day

Primary Outcome Measure

Serum prostate specific antigen [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT Southwestern Medical CenterDallasTexas75390
Maricruz Ibarra
[email protected]
214-645-8788
Jessica Williams
[email protected]
214-648-9195
Yair Lotan, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Dallas, TX

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
UT Southwestern Medical Center· Dallas, TX

Related Studies